CFTR and cystic fibrosis: Stalvey and co-workers (167) assessed linear growth and weight in 83 children with cystic fibrosis, 6 to 11 y, enrolled in two clinical trials, the longitudinal, observational GOAL study and the placebo-controlled ENVISION study to evaluate the effects of ivacaftor, a CFTR potentiator.